MetaADEDB 2.0 @ LMMD
Sincalide
(IZTQOLKUZKXIRV-YRVFCXMDSA-N)
Structure
SMILES
CSCC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CC(=O)O)CCSC)Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)Cc1ccc(cc1)OS(=O)(=O)O
Type(s)
Approved
ATC code(s)
V04CC03
Molecular Formula:
C49H62N10O16S3
Molecular Weight:
1143.270
Log P:
3.8883
Hydrogen Bond Acceptor:
27
Hydrogen Bond Donor:
13
TPSA:
485.78
CAS Number(s):
25126-32-3
Synonym(s)
1.
Sincalide
2.
CCK-8
3.
Cholecystokinin Octapeptide
4.
CCK-OP
5.
Cholecystokinin Pancreozymin C-Terminal Octapeptide
6.
H-Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
7.
Kinevac
8.
OP-CCK
9.
SQ-19,844
10.
SQ-19844
11.
Syncalide
12.
Cholecystokinin Pancreozymin C Terminal Octapeptide
13.
SQ 19,844
14.
SQ 19844
15.
SQ19,844
16.
SQ19844
External Link(s)
MeSHD012844
PubChem Compound9833444
BindingDB21148
21147
ChEBI135946
CHEMBLCHEMBL1121
DrugBankDB09142
DrugCentral4627
IUPHAR/BPS Guide to PHARMACOLOGY864
KEGGdr:D05845
Therapeutic Target DatabaseD0I8AF
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 17US FAERS
2No adverse eventFAERS: 17US FAERS
3Post procedural complicationFAERS: 5US FAERS
4NauseaFAERS: 4SIDER
US FAERS
5ChillsFAERS: 3US FAERS
6FatigueFAERS: 3US FAERS
7Abdominal discomfortFAERS: 2SIDER
US FAERS
8Expired product administeredFAERS: 2US FAERS
9MyalgiaFAERS: 2US FAERS
10Abdominal PainFAERS: 1SIDER
US FAERS
11Accidental exposure to productFAERS: 1US FAERS
12Accidental exposureFAERS: 1US FAERS
13AstheniaFAERS: 1US FAERS
14Candida test positiveFAERS: 1US FAERS
15Contrast media reactionFAERS: 1US FAERS
16DiscomfortFAERS: 1SIDER
US FAERS
17DizzinessFAERS: 1SIDER
US FAERS
18ExtravasationFAERS: 1US FAERS
19Eye painFAERS: 1US FAERS
20Feeling abnormalFAERS: 1US FAERS
21FlushingFAERS: 1SIDER
US FAERS
22HeadacheFAERS: 1SIDER
US FAERS
23Hepatobiliary scan abnormalFAERS: 1US FAERS
24Injection site erythemaFAERS: 1US FAERS
25Laboratory test interferenceFAERS: 1US FAERS
26LaryngospasmFAERS: 1US FAERS
27MalaiseFAERS: 1US FAERS
28Medication ErrorFAERS: 1US FAERS
29MydriasisFAERS: 1US FAERS
30PainFAERS: 1SIDER
US FAERS
31Pelvic fluid collectionFAERS: 1US FAERS
32PregnancyFAERS: 1US FAERS
33Product closure issueFAERS: 1US FAERS
34Product label issueFAERS: 1US FAERS
35Product use issueFAERS: 1US FAERS
36Supraventricular tachycardiaFAERS: 1US FAERS
37SwellingFAERS: 1US FAERS
38TachycardiaFAERS: 1US FAERS
39TremorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
40Vascular ruptureFAERS: 1US FAERS
41White blood cell count decreasedFAERS: 1US FAERS
42Wrong drug administeredFAERS: 1US FAERS
43Abdominal CrampsSIDER
44Amnesia24309294CTD
45Anorexia15879057CTD
46Delayed gastric emptyingSIDER
47DermatitisSIDER
48Erythema MultiformeCanada Vigilance: 1Canada Vigilance
49ErythemaCanada Vigilance: 2Canada Vigilance
SIDER
50HypersensitivitySIDER
51HypotensionSIDER
52Impaired gastric emptyingSIDER
53LightheadednessSIDER
54Lip swellingCanada Vigilance: 1Canada Vigilance
55Mouth swellingCanada Vigilance: 1Canada Vigilance
56NumbnessSIDER
57Seizures6316193CTD
58ShockSIDER
59SneezingSIDER
60Stomach acheSIDER
61SweatingSIDER
62SyncopeSIDER
63UrticariaCanada Vigilance: 2Canada Vigilance
64VomitingSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.